112 related articles for article (PubMed ID: 2714515)
1. A hormone-regulated pro-cathepsin D secreted by human mammary cancer cells.
Capony F; Garcia M; Montcourrier P; Cavailles V; Augereau P; Briozzo P; Vignon F; Rochefort H
Biochem Soc Trans; 1989 Feb; 17(1):31-3. PubMed ID: 2714515
[No Abstract] [Full Text] [Related]
2. Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.
Rochefort H; Augereau P; Briozzo P; Capony F; Cavailles V; Freiss G; Garcia M; Maudelonde T; Morisset M; Vignon F
Biochimie; 1988 Jul; 70(7):943-9. PubMed ID: 3145027
[TBL] [Abstract][Full Text] [Related]
3. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.
Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H
Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin D in breast cancer.
Rochefort H
Breast Cancer Res Treat; 1990 Jul; 16(1):3-13. PubMed ID: 2207345
[TBL] [Abstract][Full Text] [Related]
5. Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D.
Brouillet JP; Spyratos F; Hacene K; Fauque J; Freiss G; Dupont F; Maudelonde T; Rochefort H
Eur J Cancer; 1993; 29A(9):1248-51. PubMed ID: 8343262
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.
Rochefort H; Cavailles V; Augereau P; Capony F; Maudelonde T; Touitou I; Garcia M
J Steroid Biochem; 1989; 34(1-6):177-82. PubMed ID: 2626016
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D and breast cancer.
Westley BR; May FE
Eur J Cancer; 1996 Jan; 32A(1):15-24. PubMed ID: 8695224
[No Abstract] [Full Text] [Related]
8. Tamoxifen treatment increases the concentration of 52K-cathepsin D and its precursor in breast cancer tissue.
Maudelonde T; Domergue J; Henquel C; Freiss G; Brouillet JP; Simony J; Pujol H; Rochefort H
Cancer; 1989 Apr; 63(7):1265-70. PubMed ID: 2920355
[TBL] [Abstract][Full Text] [Related]
9. A two-site immunoenzymometric assay of 52-kDa pro-cathepsin D, and its use in human breast diseases.
Freiss G; Vignon F; Pau B; Paolucci F; Rochefort H
Clin Chem; 1989 Feb; 35(2):234-7. PubMed ID: 2644058
[TBL] [Abstract][Full Text] [Related]
10. Significance of the tumor protease cathepsin D for the biology of breast cancer.
Dian D; Heublein S; Wiest I; Barthell L; Friese K; Jeschke U
Histol Histopathol; 2014 Apr; 29(4):433-8. PubMed ID: 24265119
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D: an independent prognostic factor for metastasis of breast cancer.
Spyratos F; Maudelonde T; Brouillet JP; Brunet M; Defrenne A; Andrieu C; Hacene K; Desplaces A; Rouëssé J; Rochefort H
Lancet; 1989 Nov; 2(8672):1115-8. PubMed ID: 2572846
[TBL] [Abstract][Full Text] [Related]
12. Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.
Maudelonde T; Brouillet JP; Roger P; Giraudier V; Pages A; Rochefort H
Eur J Cancer; 1992; 28A(10):1686-91. PubMed ID: 1389486
[TBL] [Abstract][Full Text] [Related]
13. Expression of chimeric human aspartic proteinases.
Chirgwin JM; Schultz S; Sachdev D
Adv Exp Med Biol; 1998; 436():139-46. PubMed ID: 9561211
[No Abstract] [Full Text] [Related]
14. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
[TBL] [Abstract][Full Text] [Related]
15. Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells.
Freiss G; Vignon F; Rochefort H
Cancer Res; 1988 Jul; 48(13):3709-15. PubMed ID: 2454153
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D and prognosis in breast cancer: one piece of a larger puzzle?
Emmert-Buck MR
Hum Pathol; 1996 Sep; 27(9):869-71. PubMed ID: 8816879
[No Abstract] [Full Text] [Related]
17. Human cathepsin D precursor is associated with a 60 kDa glycosylated polypeptide.
Grässel S; Hasilik A
Biochem Biophys Res Commun; 1992 Jan; 182(1):276-82. PubMed ID: 1531012
[TBL] [Abstract][Full Text] [Related]
18. Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment.
Laurent-Matha V; Huesgen PF; Masson O; Derocq D; Prébois C; Gary-Bobo M; Lecaille F; Rebière B; Meurice G; Oréar C; Hollingsworth RE; Abrahamson M; Lalmanach G; Overall CM; Liaudet-Coopman E
FASEB J; 2012 Dec; 26(12):5172-81. PubMed ID: 22898924
[TBL] [Abstract][Full Text] [Related]
19. Human breast milk contains procathepsin D--detection by specific antibodies.
Vĕtvicka V; Vágner J; Baudys M; Tang J; Foundling SI; Fusek M
Biochem Mol Biol Int; 1993 Aug; 30(5):921-8. PubMed ID: 8220241
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.
Nikolić-Vukosavljević D; Markićević M; Grujić-Adanja G; Petrović A; Kanjer K; Nesković-Konstantinović Z
Clin Exp Metastasis; 2005; 22(4):363-8. PubMed ID: 16170672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
